Oragenics, Inc. OGEN
Set alert
0.38 USD +0.01 +1.97%
As of Nov 3, 12:11 PM ET
0.3705 Day range 0.3889
0.35 52-week range 1.22
- YTD
- -51.60%
- 1 year
- -69.06%
- Open
- 0.3839
- Prev close
- 0.3702
- Mkt cap
- 1.67M
- Vol
- 4.34K
- Avg vol
- 28.81K
- EPS
- -2.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.3705
- High
- 0.3889
- Forward P/E
- -0.03
- Beta
- 0.48
- Short ratio
- 0.43
- Inst. own
- 11.13%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.3272
- 200-d avg
- 0.981
- 1y target
- 0.00
6M chart
Signals (28)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 27, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 18, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| RSI: Oversold | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 10, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 7, 2026 | 3 months ago |
| SMA: Bearish | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
Newest 20 of 28.
Financial health
Altman Z-Score
-63.79 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.2×
FY 2016 5y median -18.4× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016 5y median 29.2× FY 2025
P/FCF -0.0×
FY 2016 5y median -24.8× FY 2025
EV/EBITDA -0.0×
FY 2016 5y median -18.3× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -547310.7%
FY 2016 5y median -4.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -118.9%
FY 2016 5y median -109.8% FY 2025
ROIC -108.5%
FY 2016 5y median -108.5% FY 2025
ROA -97.8%
FY 2016 5y median -97.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 11.3%
FY 2016 FY 2025
EPS (diluted) -185.0%
FY 2016 FY 2025
Free Cash Flow -107448.9%
FY 2016 FY 2025
Financial Health
Current Ratio 5.6×
FY 2016 5y median 5.6× FY 2025
Quick Ratio 5.6×
FY 2016 5y median 5.6× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.0×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -11.9×
FY 2016 5y median -683× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
